-
Safety Alert: Aliskiren-containing Medications - New Warning and Contraindication
Apr. 20, 2012 -
Call for Comment on the American Heart Association's Cardiac Center of Excellence open through May 4, 2012
Apr. 4, 2012 -
FDA: Statin Drugs - Drug Safety Communication: Class Labeling Change
Feb. 28, 2012 -
FDA Drug Safety Communication: Planned return of CardioGen-82 to market with new Boxed Warning
Feb. 16, 2012 -
ALTITUDE (aliskiren) trial terminated because of increase in adverse events.
Dec. 20, 2011 -
FDA Drug Safety Communication: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events
Dec. 19, 2011 -
FDA approves mechanical cardiac assist device for children with heart failure.
Dec. 19, 2011 -
FDA approves first generic version of cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).
Dec. 1, 2011 -
NHLBI announces funding opportunities for research relevant to the Family Smoking Prevention and Tobacco Control Act
PAR-12-010 (R01) | PAR-12-011 (U01) -
FDA approves rivaroxaban to prevent stroke in non-valvular atrial fibrillation
Nov. 4, 2011 -
FDA approves first artificial aortic heart valve placed without open-heart surgery
Nov. 2, 2011 -
Draft Standards and Performance Measures for Comprehensive Stroke Certification available for comment until Nov. 9
Oct. 11, 2011 -
Alert -- Clinical trial stopped after treatment with combination antiplatelet therapy (clopidogrel plus aspirin) increased risk of major hemorrhage and death.
Oct. 2, 2011 -
FDA to hold a public workshop on Magnetic Resonance Imaging (MRI) Safety, October 25-26
Sep. 20, 2011 | Meeting Announcement -
Safety information on Brilinta (ticagrelor): Boxed warning says daily aspirin doses above 100 milligrams decrease effectiveness
Aug 18, 2011 | AZ Drug Warning Letter (PDF) -
FDA approves antiplatelet drug ticagrelor to reduce cardiovascular death and heart attack in patients with acute coronary syndromes
Jul 20, 2011 -
ACS-CAD Data Standards Draft Now Available for Public Comment
Jul 11, 2011 -
FDA reviews increased risk of death and CV events with dronedarone in permanent
Jul 7, 2011 -
FDA Alert: Erythropoiesis-stimulating agents used in CKD patients may lead to increased risk of cardiovascular events
Jun 24, 2011 -
FDA limits the use of simvastatin 80 mg because of increased risk of myopathy
Jun 8, 2011 -
NIH/NHLBI stops AIM-HIGH clinical trial on combination cholesterol treatment (statin plus niacin)
May 26, 2011 -
NINDS Clinical Alert: SAMMPRIS trial stops enrollment
Apr 11, 2011 -
FDA: Low Magnesium Levels Can Be Associated With Long-Term Use of Proton Pump Inhibitors
Mar 2, 2011